| |
| |
|
| Insider
Information: |
Girshick Birgit |
| Relationship: |
Corporate Executive VP... |
| City: |
Wilmington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
50,512 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,441,336 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
50,512 |
|
|
| Total
Value |
$10,441,336 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
4
|
|
Stock
price went up :
|
1
|
4
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
4.0
|
| Percentage
Gain/Loss : |
 10.0%
|
187.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Charles River Laboratories Inter... |
CRL |
Corporate Executive VP... |
2024-05-31 |
50,512 |
2018-02-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & COO |
• • – |
2024-05-28 |
4 |
D |
$217.21 |
$28,672 |
D/D |
(132) |
46,890 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & COO |
• • – |
2024-05-29 |
4 |
D |
$214.51 |
$46,334 |
D/D |
(216) |
46,674 |
0 |
- |
|
| CRL |
Charles River Laboratorie... |
Corporate Executive VP & COO |
• • – |
2024-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,838 |
50,512 |
0 |
- |
|
78 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
